Interleukin 4 receptor, interleukin 17 and clinical presentation of chronic EAA

M. Sterclova, M. Vasakova, R. Matej, P. Mandakova (Prague, Czech Republic)

Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Session: Sarcoidosis and other granulomatosis
Session type: Thematic Poster Session
Number: 3789
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Sterclova, M. Vasakova, R. Matej, P. Mandakova (Prague, Czech Republic). Interleukin 4 receptor, interleukin 17 and clinical presentation of chronic EAA. Eur Respir J 2013; 42: Suppl. 57, 3789

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013

TNF-alpha, IL-8, IL-6 levels in serum of sarcoidosis patients with different clinical course
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013


Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study
Source: Eur Respir J 2010; 35: 540-548
Year: 2010



Serum interleukin 6 levels predict disease progression in scleroderma-associated interstitial lung disease
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


New IL-1 family IL-38 is highly expressed in alveolar cells of drug-induced lung injury and idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD pathogenesis
Year: 2016

Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 551s
Year: 2006

Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011

The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013


Polymorphisms of IL-4, IL-10, and TNF-α gene in chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 442s
Year: 2005

Investigation of alarmins, interleukin (IL-)23 and IL-36 sputum levels in chronic airway obstructive diseases.
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019

Neutrophil chemokine receptor (CXCR1 and 2) gene expression and biopsy neutrophilia in severe exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001

Release of IL-1b, IL-6 and TNF-a after pulmonary rehabilitation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Physiological response to exercise performance
Year: 2008

Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013


Polymorphisms of interleukin-10 and its receptor and lung function in COPD
Source: Eur Respir J 2007; 29: 1120-1126
Year: 2007



Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis
Source: Eur Respir J 2011; 38: 1355-1360
Year: 2011



Increased laminin deposition and expression of TGF-beta in bronchial biopsies of children with chronic obstructive respiratory diseases
Source: Annual Congress 2013 –Paediatric bronchology
Year: 2013


Erdheim-Chester disease: Patterns and pulmonary involvement
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Rituximab for the treatment of chronic hypersensitivity pneumonitis
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015

Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients
Source: Eur Respir J 2003 Dec 01;22(6):920-925
Year: 2003